Steward Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Steward Financial Group’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$37K	Buy	46 +1	+2%	+$786	0.01%	176
2023 Q2	$32K	Sell	45 -12	-21%	-$9.25K	0.01%	188
2023 Q1	$46K	Buy	57 +18	+46%	+$13.6K	0.02%	92
2022 Q4	$28K	Buy	+39	New	+$28.8K	0.01%	101
2022 Q3	–	Sell	-39	Closed	-$23K	–	1040
2022 Q2	$23K	Buy	39 +9	+30%	+$5.85K	0.02%	160
2022 Q1	$20K	Buy	+30	New	+$19K	0.02%	158

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Steward Financial Group's REGN Position: Q3 2023 in Review

Steward Financial Group increased its Regeneron Pharmaceuticals (REGN) stake by 2.2% in Q3 2023, buying an estimated $786 and bringing the position to 46 shares worth $37K. The position accounts for 0.01% of the portfolio, ranked #176.

Steward Financial Group first reported a position in REGN in Q1 2022 and has held it in 6 quarters since. The position peaked at $46K in Q1 2023. 1,177 funds tracked by Wall St. Rank hold REGN as of Q3 2023.

Steward Financial Group held 46 shares of Regeneron Pharmaceuticals worth $37K as of Q3 2023.
Steward Financial Group bought 1 Regeneron Pharmaceuticals share in Q3 2023, an estimated $786.
Regeneron Pharmaceuticals made up 0.01% of Steward Financial Group's portfolio in Q3 2023, its #176 holding.
Steward Financial Group first reported a position in Regeneron Pharmaceuticals in Q1 2022 and has held it in 6 quarters since.
Steward Financial Group's Regeneron Pharmaceuticals position peaked at $46K in Q1 2023.
1,177 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.